In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease

Neurology

Volumn 41, Issue 1, 1991, Pages 114-120

  Matthews, P M ^a   Allaire, C ^a   Shoubridge, E A ^a   Karpati, G ^a   Carpenter, S ^a   Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MALE; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; MYASTHENIA GRAVIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPECTROSCOPY;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CHILD, PRESCHOOL; ESTERS; HUMAN; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGE; MITOCHONDRIA, MUSCLE; MUSCLES; MUSCULAR DISEASES; PHOSPHOCREATINE; PHOSPHORUS; SENSITIVITY AND SPECIFICITY;

EID: 0025968255     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.41.1.114     Document Type: Article

References (35)

1. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC. Mitochondrial myopathies. Ann Neurol 1985;17:521-538.
2. Radda GK, Bore PJ, Gadian DG, et al. 31P NMR examination of two patients with NADH-CoQ dehydrogenase deficiency. Nature 1982;295:608-609.
3. Arnold DL, Taylor D.J, Radda GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
4. Argov Z, Bank WJ, Maris J, Peterson P, Chance B. Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 1987;37:257-262.
5. Carpenter S, Karpati G. Skeletal muscle pathology. New York: Churchill-Livingstone, 1984.
6. Srere PA. Citrate synthase. Methods Enzymol 1969;13:3-11.
7. Hatefi Y. Preparation and properties of NADH: ubiquinone ox- idoreductase (complex I), EC 1.6.5.3. Methods Enzymol 1978;53:11-14.
8. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. J Cell Biol 1967;32:415-438.
9. Hatefi Y, Stiggall DL. Preparation and properties of succinate: ubiquinone oxidoreductase (complex II). Methods Enzymol 1978;53:21-27.
10. DiMauro S, Servidei S, Zeviani M, et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987;22:498-506.
11. Ackermann JJH, Grove TH, Wong GG, Gadian DG, Radda GK. Mapping of metabolites in whole animals by 3IP NMR using surface coils. Nature 1980;283:167-170.
12. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of:,1P NMR. Magn Reson Med 1984;1:307-315.
13. Garlick PB, Radda GK, Seeley PJ. Studies of acidosis in the ischemic heart by phosphorus nuclear magnetic resonance. Biochem J 1979;184:547-554.
14. Chance B, Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol 1956;17:65-134.
15. Chance B, Leigh JS Jr, Clark BJ, et al. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci USA 1985;82:8384-8388.
16. Newman RJ, Bore PJ, Chan L, et al. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J Clin Res 1982;284:1072-1074.
17. Bank W, Argov Z, Leigh JS, Chance B. The value of:nP NMR in the diagnosis and monitoring of human myopathies. Ann N Y Acad Sci 1987;508:448-450.
18. Zochodne DW, Thompson RT, Driedger AA, Strong MJ, Gravelle D, Bolton CF. Metabolic changes in human muscle denervation: topical:,1P NMR spectroscopy studies. Magn Reson Med 1988;7:373-383.
19. McCully KK, Argov Z, Boden BP, Brown RL, Bank WJ, Chance B. Detection of muscle injury in humans with:ilP magnetic resonance spectroscopy. Muscle Nerve 1988;11:212-216.
20. Reznick M, Hansen JL. Mitochondria in degenerating and regenerating skeletal muscle. Arch Pathol 1969;87:601-608.
21. Karpati G, Carpenter S. Idiopathic inflammatory myopathies. Curr Opin Neurol Neurosurg 1988;1:806-814.
22. Karpati G, Carpenter S, Melmed C, Eisen AA. Experimental ischemic myopathy. J Neurol Sci 1974;23:129-161.
23. Janssen JW, van Hardeveld C, Kassenaar AAH. Evidence for a different response of red and white skeletal muscle of the rat in different thyroid states. Acta Endocrinol (Copenh) 1978;87:768-775.
24. Baldwin KM, Ernst SB, Herrick RE, Hooker AM, Mullin WJ. Exercise capacity and cardiac function in trained and untrained thyroid-deficient rats. J Appi Physiol 1980;49:1022-1026.
25. Baldwin KM, Hooker AM, Herrick RE, Schrader LF. Respiratory capacity and glycogen depletion in thyroid-deficient muscle. J Appi Physiol 1980;49:102-106.
26. Ruff R. Endocrine myopathies. In: Engel AG, Banker BQ, eds. Myology, voi 2. New York: McGraw-Hill, 1986:1871-1906.
27. Thulborn KR, Ackerman JJH. Absolute molar concentration by NMR in inhomogeneous B,: a scheme for analysis of in vivo metabolites. J Magn Reson 1983;55:357-371.
28. Narayana PA, Jackson EF, Hazle JD, Foteclar LK, Kulkorn MV, Flamig DP. In vivo localized proton spectroscopic studies of human gastrocnemius muscle. Magn Reson Med 1988;8:151-159.
29. Cordoso M, Shoubridge E, Arnold D, Leveille M, Prud’homme M, Viney P. N MR monitoring of the energy status of skeletal muscle during hemodialysis using acetate. Clin Invest Med 1988;11:292-296.
30. Chalovic J M, Burt CT, Cohen SM, Barany M. Identification of an unknown:!IP nuclear magnetic resonance from dystrophic chicken as L-serine ethanolamine phosphodiester. Arch Biochem Biophys 1977;182:683-689.
31. Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconer- Smith J. Examination of a case of suspected McArdle’s syndrome by:,1P NMR. N Engl J Med 1981;304:1338-1342.
32. Duboc D, Jehenson P, Tran Dinh S, Marsac C, Syrota A, Fardeau M. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology 1987;37:663-671.
33. Argov Z, Bank WJ, Maris J, Leigh JS, Chance B. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by "P nuclear magnetic resonance spectroscopy. Ann Neurol 1987;22:46-51.
34. Matthews PM, Shoubridge EA, Karpati G, Carpenter S, Andermann F, Arnold DL. In vivo phosphorus magnetic resonance spectroscopy in the evaluation of progressive myoclonus epilepsy with abnormal mitochondria [Abstract], Neurology 1989;(Suppl 1):257.
35. Abdoullah A, Matthews PM, Shoubridge EA, et al. A pathogenic role for impaired energy metabolism in late onset cerebellar ataxias [Abstract]. Ann Neurol 1989;26:139.